Jakob Dupont

SVP & Chief Medical Officer, OncoMed.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2026Sold 35,000 shares at $3.06 of Pyxis Oncology, Inc.⁸
Jun 30, 2026Exercised options 35,000 shares at $1.60 of Pyxis Oncology, Inc.⁸
Mar 26, 2024Granted 38,741 shares of Pyxis Oncology, Inc.⁹
Mar 2, 2023Sold 5,074 shares at $3.63 of Atara Biotherapeutics, Inc.⁷
Mar 1, 2023Granted 141,328 shares of Atara Biotherapeutics, Inc.¹⁰
Nov 16, 2022Sold 1,124 shares at $4.49 of Atara Biotherapeutics, Inc.¹¹
Nov 16, 2022Sold 3,218 shares at $4.49 of Atara Biotherapeutics, Inc.¹¹
Aug 16, 2022Sold 4,124 shares at $5.03 of Atara Biotherapeutics, Inc.¹²
May 17, 2022Sold 3,873 shares at $5.32 of Atara Biotherapeutics, Inc.¹³
Mar 1, 2022Sold 2,221 shares at $9.86 of Atara Biotherapeutics, Inc.¹⁴
Mar 1, 2022Granted 78,506 shares of Atara Biotherapeutics, Inc.¹⁴
Feb 10, 2022Sold 5,000 shares at $16.00 of Atara Biotherapeutics, Inc.¹⁵
Feb 10, 2022Exercised options 5,000 shares at $9.58 of Atara Biotherapeutics, Inc.¹⁵
Jan 3, 2022Sold 5,000 shares at $16.01 of Atara Biotherapeutics, Inc.¹⁶
Jan 3, 2022Exercised options 5,000 shares at $9.58 of Atara Biotherapeutics, Inc.¹⁶
Dec 1, 2021Sold 5,000 shares at $17.94 of Atara Biotherapeutics, Inc.¹⁷
Dec 1, 2021Exercised options 5,000 shares at $9.58 of Atara Biotherapeutics, Inc.¹⁷
Nov 16, 2021Sold 2,199 shares at $17.12 of Atara Biotherapeutics, Inc.¹⁸
Nov 2, 2021Sold 5,000 shares at $16.41 of Atara Biotherapeutics, Inc.¹⁹
Nov 2, 2021Exercised options 5,000 shares at $9.58 of Atara Biotherapeutics, Inc.¹⁹

The numbers on this page point here. Each one links to the record it came from.